[eDisclosure Notice] KOSDAQ - 7 Days
◆J-Way = Decided on a third-party allotment paid-in capital increase to raise 2 billion KRW for operating funds and 5 billion KRW for acquiring securities of other corporations.
◆Neofect = Registered with the U.S. Food and Drug Administration (FDA) for the rehabilitation training device 'Smart Balance.'
◆RSUPPORT = Decided to dispose of treasury stock worth 30.03 million KRW.
◆Hansol C&P = Decided on a bonus issue allocating 4 shares for every 1 common share.
◆BioVille = Applied for commencement of rehabilitation proceedings at the Seoul Bankruptcy Court on the 1st. The reason for the application was explained as 'seeking business normalization through the commencement of rehabilitation proceedings.'
Hot Picks Today
As Samsung Falters, Chinese DRAM Surges: CXMT Returns to Profit in Just One Year
- "Most Americans Didn't Want This"... Americans Lose 60 Trillion Won to Soaring Fuel Costs
- Trump: "No Concessions to Iran... They Will Soon Know What's Coming"
- Samsung Union Member Sparks Controversy With Telegram Post: "Let's Push KOSPI Down to 5,000"
- "Why Make Things Like This?" Foreign Media Highlights Bizarre Phenomenon Spreading in Korea
◆T-Robotics = Decided to increase short-term borrowings by 5 billion KRW.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
